N/A
N=200
Lung Ultrasonography vs Fiberoptic Bronchoscopy for Aiding Lung Collapse in Patient Using Double Lumen Tube
Lung Diseases · Ultrasonography · Fiberoptic Bronchoscopy · One Lung Ventilation · Thoracic Surgery
Bottom Line
View on ClinicalTrials.gov: NCT03314519 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Number of Patients of Lung Collapse in Ultrasonography and Fiberoptic Bronchoscopy — 89; 83 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lung ultrasonography by experienced anaesthesiologist (Diagnostic_test); Fiberoptic bronchoscopy for double lumen tube's position (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mahidol University
- Primary completion
- Jul 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients of Lung Collapse in Ultrasonography and Fiberoptic Bronchoscopy |
89; 83 | — |
| SECONDARY Timing to Detect Lung Collapse |
14; 9 | — |
| SECONDARY Accuracy of Detection of Lung Collapse in Ultrasonography Method in Cardiovascular and Thoracic Anesthesia Fellow |
89; 83 | — |
Summary
The study contains the result from a comparison of diagnostic outcomes about lung collapse by using lung ultrasonography as a new diagnostic test compares to fiberoptic bronchoscopy as the standard test.
Eligibility Criteria
Inclusion Criteria
- Adult patients, age ≥18 years old
- American Society of Anesthesiologists(ASA) physical status classification I - III
- Scheduled for elective thoracic surgery which requires One lung ventilation(OLV) with Left-sided double lumen tube
Exclusion Criteria
- Anticipated difficult intubation or with the tracheostomy tube
- Patient with pneumothorax, pleural effusion, emphysema or past history of pleurodesis
- Patient with deranges pulmonary function test (out of forced expiration volume in 1 s, total lung capacity, forced vital capacity <50% of the predicted values)
- The patient refuses to participate.
Data sourced from ClinicalTrials.gov (NCT03314519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.